ParkerVision Expands German Infringement Case Against Apple
Feb 13, 2017 12:00 pm UTC| Business
JACKSONVILLE, Fla., Feb. 13, 2017 -- ParkerVision, Inc. (NASDAQ:PRKR), a developer, manufacturer and marketer of semiconductor technology solutions for wireless applications, announced today that its wholly-owned German...
UPDATE -- Cellectar Biosciences to Present at 2017 BIO CEO & Investor Conference
Feb 13, 2017 12:00 pm UTC| Business
MADISON, Wis., Feb. 13, 2017 -- Cellectar Biosciences, Inc. (Nasdaq:CLRB), an oncology-focused, clinical stage biotechnology company, announced today that its president and CEO, Jim Caruso, will present at the 2017 BIO...
Feb 13, 2017 12:00 pm UTC| Business
ALAMEDA, Calif., Feb. 13, 2017 -- OncoCyte Corporation (NYSE MKT:OCX), a developer of novel, non-invasive blood based tests for the early detection of cancer, announced today that William Annett, Chief Executive...
Feb 13, 2017 12:00 pm UTC| Business
LA JOLLA, Calif., Feb. 13, 2017 -- PICO Holdings, Inc. (Nasdaq: PICO) today announced that the Company will host an investor conference call and audio webcast on Thursday, March 2, 2017 at 8:00 a.m. Pacific Time/11:00...
Anavex Life Sciences Strengthens Board of Directors
Feb 13, 2017 12:00 pm UTC| Business
NEW YORK, Feb. 13, 2017 -- Anavex Life Sciences Corp. (“Anavex” or the “Company”) (Nasdaq:AVXL), a clinical-stage biopharmaceutical company developing differentiated therapeutics for the treatment of neurodegenerative...
Axsome Therapeutics to Present at the 2017 RBC Capital Markets Global Healthcare Conference
Feb 13, 2017 12:00 pm UTC| Business
NEW YORK, Feb. 13, 2017 -- Axsome Therapeutics, Inc. (NASDAQ:AXSM), a clinical-stage biopharmaceutical company developing novel therapies for the management of central nervous system (CNS) disorders, today announced...
Neuralstem to Present at BIO CEO & Investor Conference
Feb 13, 2017 11:58 am UTC| Business
GERMANTOWN, Md., Feb. 13, 2017 -- Neuralstem, Inc. (Nasdaq:CUR), a biopharmaceutical company focused on the development of central nervous system therapies based on its neural stem cell technology, announces that Rich...